C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
01/2007
01/04/2007	WO2006122003A3 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
01/04/2007	US20070004675 Inhibitors of VEGF receptor and HGF receptor signaling
01/03/2007	EP1738766A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
01/03/2007	EP1737845A2 Disalt inhibitors of il-12 production
01/03/2007	EP1278515B1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir
01/03/2007	CN1889959A Preventive and/or therapeutic agent for higher brain dysfunction
01/02/2007	US7157465 Adenine derivatives
01/02/2007	US7157464 Substituted piperazines
01/02/2007	US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection
01/02/2007	US7157440 Partial and full agonists of A1 adenosine receptors
01/02/2007	CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
12/2006
12/28/2006	WO2006138376A1 Prodrugs of a2b adenosine receptor antagonists
12/28/2006	WO2006136822A1 Inhibitor compounds
12/28/2006	US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis
12/28/2006	US20060293330 Hiv replication inhibiting purine derivatives
12/28/2006	US20060293283 Prodrugs of A2B adenosine receptor antagonists
12/28/2006	US20060293274 Cancer therapy
12/28/2006	CA2612344A1 Prodrugs of a2b adenosine receptor antagonists
12/27/2006	EP1736465A1 Aniline derivatives
12/27/2006	EP1734968A2 Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
12/27/2006	EP1608317A4 Dipeptidyl peptidase inhibitors
12/27/2006	CN1886416A Comt抑制剂 Comt inhibitors
12/26/2006	US7153977 Ligands and methods for preparing same
12/26/2006	US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis
12/26/2006	US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/26/2006	US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds
12/21/2006	WO2006133611A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof
12/21/2006	US20060287349 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency
12/21/2006	US20060287344 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
12/21/2006	CA2611865A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof
12/20/2006	CN1882588A A2B adenosine receptor antagonists
12/20/2006	CN1880315A N2-quinoline or isoquinoline substituted purine derivative and its preparation method and uses
12/20/2006	CN1291028C Process for extracting tea polyphenol, caffeine as a byproduct thereof and tea polysaccharide from tea
12/20/2006	CN1290841C Process for the non-enantiomorph selective synthesis of nucleoside analogues
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/14/2006	WO2006049764A3 Methods of making 2,6-diaryl piperidine derivatives
12/14/2006	US20060281921 eg 6-[2-(dimethylamino)-1-azavinyl]-1-ethyl-3-propyl-1,3-dihydropyrimidine-2,4-dione; for making drugs for asthma and diarrhea
12/13/2006	EP1730298A1 Specific substrates for o6-alkylguanine-dna alkyltransferase
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	CN1289510C Antiviral activity possessed compound and preparation method thereof
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148229 Antidiabetic agents
12/12/2006	US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/07/2006	WO2006130736A2 High quantum yield acridinium compounds and their uses in improving assay sensitivity
12/07/2006	WO2006128693A2 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
12/07/2006	WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	WO2006128389A1 Purine derivatives
12/07/2006	WO2006075094A3 Purine derivatives compositions containing the same and use thereof against cancer
12/07/2006	CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	CA2610042A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/06/2006	EP1728793A1 9-substituted 8-oxoadenine compound
12/06/2006	EP1728792A1 8-oxoadenine compound
12/06/2006	EP1727814A1 Nucleoside analogues with antiviral activity
12/06/2006	EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006	CN1872853A Derivative of purine
12/05/2006	US7145006 PNA monomer and precursor
12/05/2006	CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/05/2006	CA2387531C Purine derivatives
11/2006
11/30/2006	WO2006127217A2 Cyclopropanecarboxylate esters of acyclovir
11/30/2006	WO2006125958A1 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
11/30/2006	US20060270691 Purine derivatives as purinergic receptor antagonists
11/30/2006	US20060270629 5-bicyclo[3.1.0]hexanyl]pyrimidine-2,4-dione derivatives useful in the treatment or prevention of epilepsy, Parkinson's disease, Huntington's disease, respiratory system disorders, cancer and arrhythmias
11/30/2006	US20060270005 Genomic library of cyanophage s-2l and functional analysis
11/30/2006	US20060269931 labeling reagents for proteins and nucleic acids; for staining genetic probes; amplification; hybridization; substituted by electrophilic groups or nucleophilic groups; conjugate linked to a target molecule; detection of nucleic acids in the diagnosis
11/29/2006	EP1725217A1 Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride
11/29/2006	CN1286845C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV)
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2234609C 2-amino-6-anilino-purine derivatives and processes for their preparation
11/23/2006	WO2006123953A1 Inhibitors of nucleoside phosphorylases and nucleosidases
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006123175A1 Preparation of famciclovir and other purine derivatives
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264629 Preparation of famciclovir and other purine derivatives
11/23/2006	US20060264448 Such as 6-Amino-9-benzyl-8-oxo-8,9-dihydro-7H-purine-2-carboxylic acid cyclopropylmethyl-amide for treatment of viral infections and immune or inflammatory disorders, including those involving Toll-Like Receptors; Hepatitis, arthritis, asthma, cancer
11/23/2006	US20060264440 Pyrazoles and methods of making and using the same
11/23/2006	US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	CA2608490A1 Preparation of famciclovir and other purine derivatives
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138401 9-(Substituted phenyl or pyridyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006122200A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	WO2006120481A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	US20060258862 Famciclovir intermediate; reaction with diethyl malonate, reduction, esterification with acetic anhydride
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	CA2607933A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607929A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607021A1 Diaryl-purines, -azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv

1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 120